MC
Matthias Christgen
Medizinische Hochschule Hannover
Research areas: Medicine · Oncology · Breast Cancer Treatment Studies · Breast Lesions and Carcinomas · HER2/EGFR in Cancer Research
0000-0002-0891-7839
Employment
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (17)
- NMD‐insensitive CDH1 mutation as a mechanism for retained E‐cadherin protein expression in lobular carcinoma in situ (LCIS) Save
- Integrative analysis of pre-treatment RNA expression signatures and recurrent genomic alterations: Link to menopausal status, short-term endocrine therapy response and disease-free survival in luminal breast cancer Save
- Deficient cell-cell cohesion is linked with lobular localization in simplified models of lobular carcinomain situ(LCIS) Save
- Molecular Characterization and Subtyping of Breast Cancer Cell Lines Provide Novel Insights into Cancer Relevant Genes Save
- Frequency of genetic alterations differs in advanced breast cancer between metastatic sites Save
- Development and validation of multivariate predictors of primary endocrine resistance to tamoxifen and aromatase inhibitors in luminal breast cancer reveal drug-specific differences Save
- Evaluation of the routine use of E‐cadherin immunohistochemistry in the typing of breast carcinomas: results of a randomized diagnostic study Save
- De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial Save
- Optimized Modeling of Metastatic Triple-Negative Invasive Lobular Breast Carcinoma Save
- Standardization in the Diagnosis of Invasive Lobular Carcinoma of the Breast Save
- Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial Save
- Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer Save
- Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2– Early Breast Cancer Save
- Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma Save
- Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions Save
- Differential impact of prognostic parameters in hormone receptor–positive lobular breast cancer Save
- ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profiling Save